Cien Saude Colet
csc
Ciência & Saúde Coletiva
Ciênc. saúde coletiva
1413-8123
1678-4561
ABRASCO - Associação Brasileira de Saúde Coletiva
Resumo
O objetivo foi estimar a associação entre fatores pré-natais e neonatais e sintomas de asma em crianças aos seis anos de idade. Foi realizado um estudo epidemiológico transversal com dados secundários provenientes de estudo de coorte com amostragem de 578 crianças. Os dados foram analisados por meio de regressão de Poisson. Do total de 578 crianças incluídas no estudo, 43,4% (IC 95% 39,4; 47,4) apresentavam sintomas de asma. As variáveis com prevalências significativamente maiores de sintomas de asma aos seis anos de idade foram: sexo masculino, com prevalência 5% maior (RP = 1,05 IC 95% 1,01; 1,11) (p = 0,043); crianças de gestantes portadoras de doenças infecciosas, com prevalência 7% maior (RP = 1,07; IC 95% 1,02; 1,13) (p = 0,011); crianças que não foram amamentadas, com prevalência 12% maior (RP = 1,12; IC 95% 1,02; 1,24) (p = 0,022), e crianças com problemas respiratórios no primeiro mês de vida, com prevalência 14% maior (RP = 1,14; IC 95% 1,01; 1,29) (p = 0,033). Concluiu-se que sexo masculino, privação de amamentação, independentemente do tempo, e problemas respiratórios no primeiro mês de vida foram associados de forma independente aos sintomas de asma aos seis anos de idade. A ocorrência de doenças infecciosas durante a gravidez foi o único fator fisiológico intra-uterino associado à ocorrência de sintomas de asma aos seis anos de idade.
Introduction
The prevalence of asthma in children is growing in several Western countries1. The increase, in addition to factors related to exposure during childhood2 such as breastfeeding and the occurrence of infections in the first month of life3, is also directly related to prenatal conditions4 such as maternal obesity5 and infections during pregnancy6, birth route7, APGAR score in the first and fifth minute of life8 and prematurity9. The prenatal period is essentially linked to the determination of the child’s health and can directly influence at the formation of the immune system, an important factor in the pathogenesis of asthma10.
According to the Global Initiative for Asthma (GINA), asthma is defined as a chronic inflammatory disease of the airways, which manifests itself through respiratory signs and symptoms such as dyspnea, wheezing, oppression or discomfort of the chest and cough11. The clinical diagnosis is a relatively complex process, based on symptoms or their triggering by irritants or aeroallergens11. Complementary tests such as spirometry and peak expiratory flow complement the diagnosis11. Because of this complexity, epidemiological studies use questionnaires that can identify individuals with asthma symptoms12. With a view to standardizing and applying greater ease and reliability to these studies, the International Study of Asthma and Allergies in Childhood (ISAAC) was designed to identify children with symptoms and severity of illness from cardinal symptoms. It consists in standardized questionnaires that have been designed and tested for applicability, validity and reproducibility12.
On the other hand, the early stages of life represent an opportunity for interventions that guarantee healthy development conditions, which can bring benefits throughout the life cycle13. The relationship between occurrences in this period and the future development of asthma might disclose factors which support health promotion actions that impact in the determination of asthma.
There are still few studies that explored the approach to factors associated with the occurrence of asthma in childhood3-9. In view of this, investigations into factors that influence the occurrence of asthma in childhood, considering prenatal and neonatal factors have become relevant.
The present study aimed to estimate the possible association between prenatal and neonatal factors and the occurrence of asthma symptoms in six-year-old children.
Methods
A cross-sectional epidemiological design study was carried out using secondary data from a cohort study called Coorte Brasil Sul14.
The study that generated the Coorte Brasil Sul14 database was carried out in Palhoça, a city in the metropolitan region of Florianópolis, 14 km from the capital city of Santa Catarina. The estimated population in 2019 was 165,299 with about 95% living in the urban area15. Palhoça has a subtropical climate (humid mesothermal and hot summer), with temperatures between 14°C and 27°C and annual relative humidity ranging between 82% and 84%.
The study population was composed of children born in 2009 who were followed until 2015 (when they were seis years old). The calculation of the minimum sample size for the present study followed these parameters: total population of 1,756 children born in 2009 resident and enrolled in schools in the municipality in 2015; anticipated prevalence of asthma symptoms unknown (p = 50.0%) and a relative error of 4%, which generated the number of 448. Since the total number of children in the database with all information needed was 578, it was decided to include all children with such information in the present study.
The study Coorte Brasil Sul14 collected data through interviews containing the ISAAC12 questionnaire and information about prenatal and neonatal periods, using a structured form, with children’s mothers in their homes, or in their absence, with the main caregiver of the child. Prenatal card and child’s health card were consulted to get some information as necessary, but mothers or caregivers were stimulated to remember others.
The team of researchers at Coorte Brasil Sul14, including the authors, was responsible for collecting data, together with community health agents from Palhoça, all duly trained to collect data.
In the present study, the dependent variable was the mother’s report of asthma symptoms at six years of age according to ISAAC question “Has your child had wheezing or whistling in the chest in the past 12 months?” (yes or no). The independent variables were: child sex; child ethnicity (categorized as Caucasian or non-Caucasian); mother schooling at birth (categorized as up to eight years of study completed or more than eight years); mother age at birth (categorized as less than or equal to 19, between 20 and 34, or more than 35 years); number of prenatal visits (categorized as up to six or seven or more); birth route (vaginal or cesarean section); smoking, alcohol intake, and illicit drug use in pregnancy (all, yes or no); occurrence of diabetes, hypertension, and infectious diseases in pregnancy (all, yes or no); preterm birth (categorized as 36 weeks or 37 weeks or more); weight at birth (categorized as until 2,500g or more than 2,500g); birth weight by gestational age - GA (small for GA, suitable for GA or large for GA); APGAR index in the 1st minute and in the 5th minute (categorized in up to seven or above seven); cephalic perimeter (categorized in less than 32 cm or higher than 36 cm or between 33 and 35 cm); breastfeeding independently of time, occurrence of respiratory problems in the first month; need for intubation in the first month and occurrence of jaundice (all, yes or no).
Data were exported to SPSS 18.0 software from Excel spreadsheets from the original bank, where they were analyzed using Poisson Regression with a robust estimator, hierarchized with the stepwise forward strategy. The prevalence ratios and their respective 95% confidence intervals were estimated. The hierarchical analysis model proposed for this study is shown in Figure 1, composed of three levels. Sociodemographic variables constituted the first level (child sex and ethnicity, mother’s age and schooling at birth), variables related to pregnancy conditions constituted the second level (number of prenatal consultations, way of delivery, smoking, alcohol and illegal drug use during pregnancy, diabetes, hypertension and infectious diseases in pregnancy), and variables related to birth and neonatal conditions constituted the third level (prematurity, weight at birth, weight per gestational age, APGAR on the 1th and 5th minute, head circumference, breastfeeding, respiratory problem, need for intubation and jaundice in the first month of life). The use of this model assumes that sociodemographic conditions have the potential to interfere with gestational conditions and these on neonatal conditions. Initially, a bivariate analysis was performed, with all variables of each hierarchical level. It was then elaborated a model with variables of the first level that presented p < 0.20. In this block, variables that presented p < 0.05 were kept. After, variables of the second level were added which in the bivariate analysis presented p < 0.20. At this moment, variables of the second level that presented p > 0.05 were removed from the model. Socio-demographic variables that had presented statistical significance in the first stage of the multivariate model were maintained, regardless of the level of significance presented after the introduction of variables related to pregnancy conditions. Thus, a model with two levels was created. Subsequently, variables of the third level were introduced, which in the bivariate analysis presented p < 0.20. Variables of this third level that presented a p value < 0.05 were maintained in the model, without removing the variables from the previous levels. Thus, a final model with three levels was obtained. The order of entry of variables in each step obeyed the level of statistical significance observed in the bivariate analysis.
Figure 1
Hierarchical conceptual structure, in blocks, for reporting asthma symptoms at 6 years of age.
Source: Authors.
This study respected the ethical principles established by the Brazilian National Health Council Resolution number 466/2012 and has the approval of the Research Ethics Committee of the Universidade do Sul de Santa Catarina.
Results
Of the total of 578 children included in the study, 43.4% (95% CI 39.4; 47.4) had asthma symptoms.
The values obtained in the bivariate analysis of the possible risk factors tested at the three levels of the study, in relation to the variable “asthma symptoms at 6 years of age” are shown in Table 1. Male children presented a 6% higher prevalence (PR = 1.06; 95% CI 1.01; 1.12) (p = 0.017) of asthma symptoms compared to female children. Children whose mothers used illegal drugs during pregnancy had a 15% higher prevalence (PR = 1.15; 95% CI 1.01; 1.42) (p = 0.023). Children of mothers with hypertension during pregnancy had a 13% higher prevalence (PR = 1.13; 95% CI 1.01; 1.13) (p = 0.054) and those with infectious diseases during pregnancy had a 12% higher prevalence (PR = 1.12; 95% CI 1.03; 1.21) (p = 0.008). Children who were not breastfed had a 14% higher prevalence (PR = 1.14; 95% CI 1.04; 1.26) (p = 0.006). Children with respiratory problems in the first month had a prevalence 18% higher (PR = 1.18; 95% CI 1.04; 1.33) (p = 0.183). Table 2 presents the results of the association of the level “pregnancy conditions” adjusted by the variables of this level and by the “socio-demographic” level and Table 3 of the level “birth and neonatal conditions” adjusted by the variables of this level and by the “socio-demographic” and “pregnancy conditions” levels.
Table 1
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age.
Variables
Asthma Symtomps
n
%
PRc
95% CI
p
1st Level - Socio-Demographic
Child sex
0.017
Male
148
48.1
1.06
1.01; 1.12
Female
103
38.1
1,00
Ethnicity of child
0.342
Caucasian
45
47.9
1,03
0.96; 1.11
Non-Caucasian
206
42.6
Mother’s age at birth
19 or less
31
44.3
1.01
0.92; 1.08
0.972
Between 20 and 34
193
44.1
1.04
0.93; 1.15
0.491
35 or more
23
38.3
1.00
Mother’s schooling at birth
0.300
Up to 8
116
46.8
1.03
0.97; 1.09
More than 8
121
42.3
1.00
2nd Level - Pregnancy conditions
Number of prenatal consultations
0.851
Up to 6
17
41.5
0.99
0.90; 1.09
7 or more
202
43.0
1.00
Way of delivery
0.314
Vaginal
103
41.2
1.00
Cesarean
148
45.4
1.03
0.97; 1.08
Smoking during pregnancy
0.057
Yes
58
51.3
1.07
0.99; 1.14
No
190
41.3
1.00
Alcohol in pregnancy
0.056
Yes
21
58.3
1.11
0.99; 1.25
No
218
42.0
1.00
Illegal drug use in pregnancy
0.023
Yes
7
63.6
1.15
1.01; 1.42
No
240
43.0
1.00
Diabetes in pregnancy
0.573
Yes
34
46.6
1.02
0.95; 1.11
No
205
43.1
1.00
Hypertension in pregnancy
0.054
Yes
17
60.7
1.13
1.01; 1.29
No
229
42.3
1.00
Infectious diseases in pregnancy
0.008
Yes
116
49.2
1.12
1.03; 1.21
No
122
37.9
1.00
3rd Level - Birth and neonatal conditions
Prematurity
0.301
Up to 37 weeks
30
50.0
1.05
0.96; 1.14
38 weeks or more
195
43.0
1.00
Weight at birth
0.210
Up to 2,500g
13
34.2
0.94
0.85; 1.03
More than 2,500g
234
44.7
1.00
Weight per gestational age
Large for gestational age
32
38.1
0.95
0.89; 1.02
0.192
Small for gestational age
21
40.4
0.99
0.89; 1.09
0.791
Appropriate for gestational age
169
45.7
1.00
APGAR 1th minute
0.267
Up to 7
23
54.8
1.06
0.95; 1.18
8 or more
191
45.8
1.00
APGAR 5th minute
1.000
Up to 7
4
50.0
1.02
0.81; 1.29
8 or more
209
46.4
1.00
Head circumference
0.586
Less than 32 cm or bigger than 36 cm
45
44.6
0.98
0.91; 1.05
between 33 and 34 cm
161
47.6
1.00
Breastfed
0.004
Yes
214
41.3
1.00
No
35
61.4
1.14
1.04; 1.26
Respiratory problem in the first month of life
0.006
Yes
23
65.7
1.18
1.04; 1.33
No
226
41.9
1.00
Need for intubation in the first month of life
0.183
Yes
14
56.0
1.09
0.95; 1.25
No
233
42.7
1.00
Jaundice
0.909
Yes
49
43.0
0.99
0.93; 1.06
No
200
43.6
1.00
PRc = crude prevalence ratio. 95% CI = 95% confidence interval. p = p value obtained by Poisson regression with robust estimator.
Source: Authors.
Table 2
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “pregnancy conditions” level adjusted by the variables of this level and by the variables of the “socio-demographic” level.
Variables
Asthma Symtopms
PRa
95% CI
p
Child sex
0.021
Male
1.06
1.01; 1.20
Female
1.00
Smoking during pregnancy
0.121
Yes
1.06
0.98; 1.14
No
1.00
Alcohol in pregnancy
0.277
Yes
1.06
0.95; 1.20
No
1.00
Illegal drug use in pregnancy
0.523
Yes
1.09
0.84; 1.40
No
1.00
Infectious diseases in pregnancy
0.011
Yes
1.07
1.02; 1.13
No
1.00
PRa = adjusted prevalence ratio. CI 95% = 95% confidence interval. p = p value obtained by Poisson regression with robust estimator.
Source: Authors.
Table 3
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “birth and neonatal conditions” level adjusted by the variables of this level and by the “socio-demographic” and “pregnancy conditions” levels.
Variables
Asthma Symptoms
PRa
95% CI
p
Child sex
0.043
Male
1.05
1.01; 1.11
Female
1.00
Smoking during pregnancy
0.134
Yes
1.05
0.98; 1.13
No
1.00
Infectious diseases in pregnancy
0.011
Yes
1.07
1.02; 1.13
No
1,00
Breastfed
0.022
Yes
1.00
No
1.12
1.02; 1.24
Respiratory problem in the first month of life
Yes
1.14
1.01; 1.29
0.033
No
1.00
PRa = adjusted prevalence ratio. CI 95% = 95% confidence interval. p = p value obtained by Poisson regression with robust estimator.
Source: Author.
The final model obtained in the multivariate hierarchical analysis is presented in Table 4. Variables with significantly higher prevalence of symptoms and asthma at six years of age were presented in Table 4: male gender with 5% higher prevalence (PR = 1.05 95% CI 1.01; 1.11) (p = 0.043); children of pregnant women with the occurrence of infectious diseases with 7% higher prevalence (PR = 1.07; CI 95% 1.02; 1.13) (p = 0.011); children who were not breastfed with a 12% higher prevalence (PR = 1.12; 95% CI 1.02; 1.24) (p = 0.022) and children with respiratory problems in the first month of life a 14% higher prevalence (PR = 1.14; 95% CI 1.01; 1.29) (p = 0.033).
Table 4
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Final hierarchical model.
Variables
Asthma Symptoms
PRa
95% CI
p
1st Level - Socio-Demographic
Child sex
0.043
Male
1.05
1.01; 1.11
Female
1.00
2nd Level - Pregnancy Conditions
Infectious diseases in pregnancy
0.011
Yes
1.07
1.02; 1.13
No
1.00
3rd Level - Birth and Neonatal Conditions
Breastfed
0.022
Yes
1.00
No
1.12
1.02; 1.24
Respiratory problem in the first month of life
Yes
1.14
1.01; 1.29
0.033
No
1.00
PRa = Adjusted prevalence ratio. CI 95% = 95% confidence interval. p = p value obtained by Poisson regression with robust estimator.
Source: Authors.
Discussion
The 43.4% prevalence of asthma symptoms found in this study, using the question “Has your child had wheezing or whistling in the chest in the past 12 months?” is quite high, compared to 22.9% in children of the same age in Curitiba/PR15, using the same question as outcome. The International Study of Asthma and Allergies (ISAAC) Phase 316, conducted in 20 Brazilian cities in the same age group, showed prevalence of 24.4% in Manaus/AM, 29.9% in Natal/RN and 31.2% in São Paulo/SP. However, in Itajaí/SC the prevalence was 20.6%. The methods of the present study do not allow pointing out the reasons for the different prevalence, however, it is possible to hypothesize about different socio-demographic characteristics of the populations studied and the time elapsed between studies, which could point to a trend towards an increase in the epidemiological indicators of asthma.
Asthma is a complex disease and has several determining factors that interact with its development, which is why the model of hierarchical analysis of variables was used in this study. After a careful selection of variables and analysis of them, it was found that males, the occurrence of infectious diseases in pregnancy, breast milk deprivation, and the occurrence of respiratory problems in the first month of life were independently associated with a higher prevalence of asthma symptoms at age six. Among these variables, respiratory problems in the first month of life presented the highest magnitude of the prevalence of asthma symptoms.
Male children were observed to have a 5% higher prevalence, which corroborates studies that state that being male is a risk factor during childhood, but that in adolescence, this prevalence tends to reverse17. A hypothesis that could justify this alternation of predominance would be the greater tonus and smaller diameter of the airways, which would cause a lower pulmonary flow during childhood in males and adolescence in females18. However, this is still a controversial issue, and studies analyzing the real influence of sex on the appearance of asthma symptoms in childhood are lacking.
Regarding the occurrence of infectious diseases during pregnancy, there was a 7% higher prevalence of asthma in children whose mothers reported some infectious disease during pregnancy. Infectious diseases, by generating inflammatory reactions during pregnancy, cause an increase in pro-inflammatory cytokines that cross the placental barrier, come into contact with the amniotic fluid, and expose the fetus to these substances6. On the other hand, a study points out that some diseases that alter the vaginal flora place children at risk of early microbial pathogenic colonization, since the microbiota of the maternal vaginal canal contributes to the formation of the intestinal flora of the newborn19. However, in this study the different pathogens and diseases affecting pregnant women were not investigated.
This study also investigated the association between the deprivation of breast milk in children and the occurrence of asthma. Children who were not breastfed presented a 12% higher prevalence of asthma symptoms at 6 years of age, compared with those who were breastfed, corroborating a recent study20. Breast milk is a solution that contains several immunological compounds, creating a passive immunization through bioactive components, such as IgA and IgG, which facilitate the development of defense mechanisms in children21, in addition to containing factors that stimulate the infant’s immune system22.
With regard to respiratory infections present at the beginning of life, there is evidence that, when they occur in the first month of life, they can constitute one of the main antecedents of asthma in childhood23. In this study, a 14% higher prevalence was observed in children who presented such a condition. Studies differ in explaining the pathophysiological mechanism of respiratory infections in the first month of life in the child’s body, which could trigger asthma symptoms. One of the explanations points out that the infections would cause an epithelial lesion of the airways so as to make them more prone to inflammation. However, in children with an appropriate genetic background for asthma, it was not possible to conclude whether lower airway infections would act as a marker for susceptibility to asthma symptoms24.
Unexpectedly, smoking during pregnancy was not associated with the occurrence of asthma symptoms in childhood. Several studies25,26 have addressed this issue, and some have demonstrated that fetal contact with smoking compromises pulmonary growth, decreasing the diameter of the airways and favoring the appearance of pulmonary diseases. Likewise, in several studies, prematurity has been shown to be an important variable for the occurrence of asthma, due to the impairment of lung growth9, which did not occur significantly when analyzed together with other variables in this study.
The present study has some limitations. Some variables require more in-depth questions in order to better clarify the real influence of prenatal and neonatal factors on the final outcome, such as whether breastfeeding was exclusively maternal or supplemented, as well as to differentiate infectious agents in lower respiratory tract infections in order to relate the type of infection with the outcome. Because it was a questionnaire applied with the mother or the person responsible for the child, the variables that were not collected in the child’s health book may have suffered from memory bias, which could affect the reliability of the data. Similarly, the use of ISAAC does not allow the diagnosis of asthma, but rather the reporting of symptoms. Also, the cross-sectional design used in this study does not allow to study etiologic relationship.
It can be concluded that significant associations were observed among males, infectious diseases in pregnancy, time-independent breast milk deprivation and respiratory problems in the first month of life and asthma symptoms in children at six years of age. New studies are recommended, preferably longitudinal design, in order to better elucidate the determining factors of asthma in children.
References
1
1 Lundbäck B, Backman H, Lötvall J, Rönmark E. Is asthma prevalence still increasing? Expert Rev Respir Med 2016; 10(1):39-51.
Lundbäck
B
Backman
H
Lötvall
J
Rönmark
E
Is asthma prevalence still increasing
Expert Rev Respir Med
2016
10
1
39
51
2
2 Wegienka G, Zoratti E, Johnson CC. The role of the early-life environment in the development of allergic disease. Immunol Allergy Clin North Am 2015; 35(1):1-17.
Wegienka
G
Zoratti
E
Johnson
CC
The role of the early-life environment in the development of allergic disease
Immunol Allergy Clin North Am
2015
35
1
1
17
3
3 Lodge CJ, Tan DJ, Lau MX, Dai X, Tham R, Lowe AJ, Bowatte G, Allen KJ, Dharmage SC. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr 2015; 104(467):38-53.
Lodge
CJ
Tan
DJ
Lau
MX
Dai
X
Tham
R
Lowe
AJ
Bowatte
G
Allen
KJ
Dharmage
SC
Breastfeeding and asthma and allergies a systematic review and meta-analysis
Acta Paediatr
2015
104
467
38
53
4
4 Lockett GA, Huoman J, Holloway JW. Does allergy begin in utero? Pediatr Allergy Immunol 2015; 26(5):394-402.
Lockett
GA
Huoman
J
Holloway
JW
Does allergy begin in utero
Pediatr Allergy Immunol
2015
26
5
394
402
5
5 Forno E, Young OM, Kumar R, Simhan H, Celedon JC. Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma. Pediatrics 2014; 134(2):e535-e546.
Forno
E
Young
OM
Kumar
R
Simhan
H
Celedon
JC
Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma
Pediatrics
2014
134
2
e535
e546
6
6 Collier CH, Risnes K, Norwitz ER, Bracken MB, Illuzzi JL. Maternal infection in pregnancy and risk of asthma in offspring. Matern Child Health J 2013; 17(10):1940-1950.
Collier
CH
Risnes
K
Norwitz
ER
Bracken
MB
Illuzzi
JL
Maternal infection in pregnancy and risk of asthma in offspring
Matern Child Health J
2013
17
10
1940
1950
7
7 Huang L, Chen Q, Zhao Y, Wang W, Fang F, Bao Y. Is elective cesarean section associated with a higher risk of asthma? A meta-analysis. J Asthma 2015; 52(1):16-25.
Huang
L
Chen
Q
Zhao
Y
Wang
W
Fang
F
Bao
Y
Is elective cesarean section associated with a higher risk of asthma A meta-analysis
J Asthma
2015
52
1
16
25
8
8 American Academy of Pediatrics, Committee on Fetus and Newborn; American College of Obstetricians and Gynecologists and Committee on Obstetric Practice. The Apgar Score. Pediatrics 2015; 136(4):819-822.
American Academy of Pediatrics.Committee on Fetus and NewbornAmerican College of Obstetricians and Gynecologists and Committee on Obstetric Practice
The Apgar Score
Pediatrics
2015
136
4
819
822
9
9 Been JV, Lugtenberg MJ, Smets E, van Schayck CP, Kramer BW, Mommers M, Sheikh A. Preterm birth and childhood wheezing disorders: a systematic review and meta-analysis. PLoS Med 2014; 11(1):e1001596.
Been
JV
Lugtenberg
MJ
Smets
E
van Schayck
CP
Kramer
BW
Mommers
M
Sheikh
A
Preterm birth and childhood wheezing disorders a systematic review and meta-analysis
PLoS Med
2014
11
1
e1001596
10
10 Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol 2005; 116(1):16-24.
Holt
PG
Upham
JW
Sly
PD
Contemporaneous maturation of immunologic and respiratory functions during early childhood implications for development of asthma prevention strategies
J Allergy Clin Immunol
2005
116
1
16
24
11
11 Global Initiative for Asthma - GINA. Global Strategy for Asthma Management and Prevention 2017. [cited 2019 Aug 24]. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11.pdf
Global Initiative for Asthma - GINA
Global Strategy for Asthma Management and Prevention
2017
http://www.ginasthma.org/local/uploads/files/GINA_Report_2015_Aug11.pdf
12
12 Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8(3):483-491.
Asher
MI
Keil
U
Anderson
HR
Beasley
R
Crane
J
Martinez
F
Mitchell
EA
Pearce
N
Sibbald
B
Stewart
AW
International Study of Asthma and Allergies in Childhood (ISAAC) rationale and methods
Eur Respir J
1995
8
3
483
491
13
13 Cunha AJLA, Leite AJM, Almeida ISS. Atuação do pediatra nos primeiros mil dias da criança: a busca pela nutrição e desenvolvimento saudáveis. J. Pediatr (Rio J) 2015; 91(6): S44-S51.
Cunha
AJLA
Leite
AJM
Almeida
ISS
Atuação do pediatra nos primeiros mil dias da criança a busca pela nutrição e desenvolvimento saudáveis
J. Pediatr (Rio J)
2015
91
6
S44
S51
14
14 Traebert J, Lunardelli SE, Martins LGT, Santos K, Nunes RD, Lunardelli AN, Traebert E. Methodological description and preliminary results of a cohort study on the influence of the first 1,000 days of life on the children's future health. An Acad Bras Cienc 2018; 90(3):3105-3114.
Traebert
J
Lunardelli
SE
Martins
LGT
Santos
K
Nunes
RD
Lunardelli
AN
Traebert
E
Methodological description and preliminary results of a cohort study on the influence of the first 1,000 days of life on the children's future health
An Acad Bras Cienc
2018
90
3
3105
3114
15
15 Ferrari FP, Rosário Filho NA, Ribas LFO, Callefe LG. Prevalência de Asma em escolares de Curitiba - projeto ISSAC (International Study of Asthma and Allergies in Childhood). J Pediatr (Rio J) 1998; 74(4):299-305.
Ferrari
FP
Rosário
NA
Filho
Ribas
LFO
Callefe
LG
Prevalência de Asma em escolares de Curitiba - projeto ISSAC (International Study of Asthma and Allergies in Childhood)
J Pediatr (Rio J)
1998
74
4
299
305
16
16 Solé D, Wandalsen GF, Camelo-Nunes IC, Naspitz CK, ISAAC - Grupo Brasileiro. Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children?and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC), Phase 3. J Pediatr (Rio J) 2006; 82(5):341-346.
Solé
D
Wandalsen
GF
Camelo-Nunes
IC
Naspitz
CK
ISAAC - Grupo Brasileiro
Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the International Study of Asthma and Allergies in Childhood (ISAAC), Phase 3
J Pediatr (Rio J)
2006
82
5
341
346
17
17 Instituto Brasileiro de Geografia e Estatística (IBGE). Santa Catarina. Palhoça. Estimativa da população; 2019. [cited 2019 Oct 4]. Available from: www.cidades.ibge.gov.br
Instituto Brasileiro de Geografia e Estatística (IBGE)
Santa Catarina. Palhoça
Estimativa da população
2019
www.cidades.ibge.gov.br
18
18 Boechat J. Prevalência e gravidade de sintomas relacionados à asma em escolares e adolescentes no município de Duque de Caxias, Rio de Janeiro. J Bras Pneumol 2005; 31(2):111-117.
Boechat
J
Prevalência e gravidade de sintomas relacionados à asma em escolares e adolescentes no município de Duque de Caxias, Rio de Janeiro
J Bras Pneumol
2005
31
2
111
117
19
19 Luna MFG, Fisher GB, Luna JRG, Silva MGC, Almeida PC, Chiesa D. Prevalência de asma em escolares de 6 e 7 anos de idade na cidade de Fortaleza, Brasil. Braz J Allergy Immunol 2013; 1(5):279-285.
Luna
MFG
Fisher
GB
Luna
JRG
Silva
MGC
Almeida
PC
Chiesa
D
Prevalência de asma em escolares de 6 e 7 anos de idade na cidade de Fortaleza, Brasil
Braz J Allergy Immunol
2013
1
5
279
285
20
20 Keski-Nisula L, Katila ML, Remes S, Heinonen S, Pekkanen J. Intrauterine bacterial growth at birth and risk of asthma and allergic sensitization among offspring at the age of 15 to 17 years. J Allergy Clin Immunol 2009; 123(6):1305-1311.
Keski-Nisula
L
Katila
ML
Remes
S
Heinonen
S
Pekkanen
J
Intrauterine bacterial growth at birth and risk of asthma and allergic sensitization among offspring at the age of 15 to 17 years
J Allergy Clin Immunol
2009
123
6
1305
1311
21
21 Gomes MM. Aleitamento materno e a prevenção da doença alérgica: uma revisão baseada na evidência. Rev Port Med Geral Fam 2019; 35(3):203-209.
Gomes
MM
Aleitamento materno e a prevenção da doença alérgica uma revisão baseada na evidência
Rev Port Med Geral Fam
2019
35
3
203
209
22
22 Hoppu U, Kalliomaki M, Laiho K, Isolauri E. Breast milk-immunomodulatory signals against allergic diseases. Allergy 2001; 56(Suppl. 67):23-26.
Hoppu
U
Kalliomaki
M
Laiho
K
Isolauri
E
Breast milk-immunomodulatory signals against allergic diseases
Allergy
2001
56
Suppl. 67
23
26
23
23 Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol 2005; 115(6):1238-1248.
Friedman
NJ
Zeiger
RS
The role of breast-feeding in the development of allergies and asthma
J Allergy Clin Immunol
2005
115
6
1238
1248
24
24 Sorio G, Edelmuth S, Utiyama T, Almeida J. Asma: perfil da população infantil atendida na UBS Vitória Régia, Sorocaba/SP. Medicina 2017; 50(2):91-101.
Sorio
G
Edelmuth
S
Utiyama
T
Almeida
J
Asma perfil da população infantil atendida na UBS Vitória Régia, Sorocaba/SP
Medicina
2017
50
2
91
101
25
25 Beigelman A, Bacharier LB. Early-life respiratory infections and asthma development: role in disease pathogenesis and potential targets for disease prevention. Curr Opin Allergy Clin Immunol 2016;16(2):172-178.
Beigelman
A
Bacharier
LB
Early-life respiratory infections and asthma development role in disease pathogenesis and potential targets for disease prevention
Curr Opin Allergy Clin Immunol
2016
16
2
172
178
26
26 Machado MB, Borges JPA. Complicações apresentadas por recém-nascidos de mães tabagistas no período neonatal. Rev Enferm Atenção Saude 2017; 6(2):179-187.
Machado
MB
Borges
JPA
Complicações apresentadas por recém-nascidos de mães tabagistas no período neonatal
Rev Enferm Atenção Saude
2017
6
2
179
187
Funding
Research partially funded by Prosuc/Capes.
Autoria
Leonardo Esmeraldino
Faculdade de Medicina. Universidade do Sul de Santa Catarina. Av. Pedra Branca 25, Cidade Universitária. 88137-270 Palhoça SC Brasil.Universidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilFaculdade de Medicina. Universidade do Sul de Santa Catarina. Av. Pedra Branca 25, Cidade Universitária. 88137-270 Palhoça SC Brasil.
Programa de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.comUniversidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilPrograma de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.com
Programa de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.comUniversidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilPrograma de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.com
Programa de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.comUniversidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilPrograma de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.com
Leonardo Esmeraldino: conception and design, analysis and interpretation of data, review and approval of the final version of the article. Eliane Traebert: conception and design, analysis and interpretation of data, review and approval of the final of the article. Rodrigo Dias Nunes: analysis and interpretation of data, review and approval of the final version of the article. Jefferson Traebert: conception and design, analysis and interpretation of data, review and approval of the final version of the article.
Chief editors:
Romeu Gomes, Antônio Augusto Moura da Silva
SCIMAGO INSTITUTIONS RANKINGS
Faculdade de Medicina. Universidade do Sul de Santa Catarina. Av. Pedra Branca 25, Cidade Universitária. 88137-270 Palhoça SC Brasil.Universidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilFaculdade de Medicina. Universidade do Sul de Santa Catarina. Av. Pedra Branca 25, Cidade Universitária. 88137-270 Palhoça SC Brasil.
Programa de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.comUniversidade do Sul de Santa CatarinaBrazilPalhoça, SC, BrazilPrograma de Pós-Graduação em Ciências da Saúde. Universidade do Sul de Santa Catarina. Palhoça SC Brasil. jefferson.traebert@gmail.com
Table 2
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “pregnancy conditions” level adjusted by the variables of this level and by the variables of the “socio-demographic” level.
Table 3
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “birth and neonatal conditions” level adjusted by the variables of this level and by the “socio-demographic” and “pregnancy conditions” levels.
Table 4
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Final hierarchical model.
imageFigure 1
Hierarchical conceptual structure, in blocks, for reporting asthma symptoms at 6 years of age.
open_in_new
Source: Authors.
table_chartTable 1
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age.
Variables
Asthma Symtomps
n
%
PRc
95% CI
p
1st Level - Socio-Demographic
Child sex
0.017
Male
148
48.1
1.06
1.01; 1.12
Female
103
38.1
1,00
Ethnicity of child
0.342
Caucasian
45
47.9
1,03
0.96; 1.11
Non-Caucasian
206
42.6
Mother’s age at birth
19 or less
31
44.3
1.01
0.92; 1.08
0.972
Between 20 and 34
193
44.1
1.04
0.93; 1.15
0.491
35 or more
23
38.3
1.00
Mother’s schooling at birth
0.300
Up to 8
116
46.8
1.03
0.97; 1.09
More than 8
121
42.3
1.00
2nd Level - Pregnancy conditions
Number of prenatal consultations
0.851
Up to 6
17
41.5
0.99
0.90; 1.09
7 or more
202
43.0
1.00
Way of delivery
0.314
Vaginal
103
41.2
1.00
Cesarean
148
45.4
1.03
0.97; 1.08
Smoking during pregnancy
0.057
Yes
58
51.3
1.07
0.99; 1.14
No
190
41.3
1.00
Alcohol in pregnancy
0.056
Yes
21
58.3
1.11
0.99; 1.25
No
218
42.0
1.00
Illegal drug use in pregnancy
0.023
Yes
7
63.6
1.15
1.01; 1.42
No
240
43.0
1.00
Diabetes in pregnancy
0.573
Yes
34
46.6
1.02
0.95; 1.11
No
205
43.1
1.00
Hypertension in pregnancy
0.054
Yes
17
60.7
1.13
1.01; 1.29
No
229
42.3
1.00
Infectious diseases in pregnancy
0.008
Yes
116
49.2
1.12
1.03; 1.21
No
122
37.9
1.00
3rd Level - Birth and neonatal conditions
Prematurity
0.301
Up to 37 weeks
30
50.0
1.05
0.96; 1.14
38 weeks or more
195
43.0
1.00
Weight at birth
0.210
Up to 2,500g
13
34.2
0.94
0.85; 1.03
More than 2,500g
234
44.7
1.00
Weight per gestational age
Large for gestational age
32
38.1
0.95
0.89; 1.02
0.192
Small for gestational age
21
40.4
0.99
0.89; 1.09
0.791
Appropriate for gestational age
169
45.7
1.00
APGAR 1th minute
0.267
Up to 7
23
54.8
1.06
0.95; 1.18
8 or more
191
45.8
1.00
APGAR 5th minute
1.000
Up to 7
4
50.0
1.02
0.81; 1.29
8 or more
209
46.4
1.00
Head circumference
0.586
Less than 32 cm or bigger than 36 cm
45
44.6
0.98
0.91; 1.05
between 33 and 34 cm
161
47.6
1.00
Breastfed
0.004
Yes
214
41.3
1.00
No
35
61.4
1.14
1.04; 1.26
Respiratory problem in the first month of life
0.006
Yes
23
65.7
1.18
1.04; 1.33
No
226
41.9
1.00
Need for intubation in the first month of life
0.183
Yes
14
56.0
1.09
0.95; 1.25
No
233
42.7
1.00
Jaundice
0.909
Yes
49
43.0
0.99
0.93; 1.06
No
200
43.6
1.00
table_chartTable 2
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “pregnancy conditions” level adjusted by the variables of this level and by the variables of the “socio-demographic” level.
Variables
Asthma Symtopms
PRa
95% CI
p
Child sex
0.021
Male
1.06
1.01; 1.20
Female
1.00
Smoking during pregnancy
0.121
Yes
1.06
0.98; 1.14
No
1.00
Alcohol in pregnancy
0.277
Yes
1.06
0.95; 1.20
No
1.00
Illegal drug use in pregnancy
0.523
Yes
1.09
0.84; 1.40
No
1.00
Infectious diseases in pregnancy
0.011
Yes
1.07
1.02; 1.13
No
1.00
table_chartTable 3
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Variables of the “birth and neonatal conditions” level adjusted by the variables of this level and by the “socio-demographic” and “pregnancy conditions” levels.
Variables
Asthma Symptoms
PRa
95% CI
p
Child sex
0.043
Male
1.05
1.01; 1.11
Female
1.00
Smoking during pregnancy
0.134
Yes
1.05
0.98; 1.13
No
1.00
Infectious diseases in pregnancy
0.011
Yes
1.07
1.02; 1.13
No
1,00
Breastfed
0.022
Yes
1.00
No
1.12
1.02; 1.24
Respiratory problem in the first month of life
Yes
1.14
1.01; 1.29
0.033
No
1.00
table_chartTable 4
Association between variables of the prenatal, perinatal and neonatal periods and asthma symptoms at 6 years of age. Final hierarchical model.
ABRASCO - Associação Brasileira de Saúde ColetivaAv. Brasil, 4036 - sala 700 Manguinhos, 21040-361 Rio de Janeiro RJ - Brazil, Tel.: +55 21 3882-9153 / 3882-9151 -
Rio de Janeiro -
RJ -
Brazil E-mail: cienciasaudecoletiva@fiocruz.br
rss_feed
Stay informed of issues for this journal through your RSS reader